Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual center study

Naotake Funamizu; Shozo Mori; Akimasa Sakamoto; Masahiko Honjo; Kei Tamura; Katsunori Sakamoto; Kohei Ogawa; Yuzo Umeda; Taku Aoki; Yasutsugu Takada

doi:10.1038/s41598-025-02365-5

Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual center study

N Naotake Funamizu S Shozo Mori A Akimasa Sakamoto M Masahiko Honjo K Kei Tamura K Katsunori Sakamoto K Kohei Ogawa Y Yuzo Umeda T Taku Aoki Y Yasutsugu Takada

Download PDF View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Scientific Reports

Volume / Issue Vol. 15, Issue 1

Published May 16, 2025

DOI 10.1038/s41598-025-02365-5

ISSN 2045-2322

Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (10)

N

Naotake Funamizu

S

Shozo Mori

A

Akimasa Sakamoto

M

Masahiko Honjo

K

Kei Tamura

K

Katsunori Sakamoto

K

Kohei Ogawa

Y

Yuzo Umeda

T

Taku Aoki

Y

Yasutsugu Takada

Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual center study

Article Details

Journal Info

Authors (10)

Related Articles from this Journal

AI models of unstable flow exhibit hallucination

The MCAA-YOLO + XPBI integrated model provides a hybrid intelligent measurement method for predicting the body weight of Hu sheep

Application of iron nano-biofertilizers as a sustainable approach to enhance growth and micronutrient uptake in soybean

Adolescents’ status-dependent public and private conformity to prosocial and antisocial decisions in a public goods game

An explainable hierarchical capsule network framework for supporting expert sensory evaluation of herbal medicines with natural language generation